Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ten of our researchers feature in the Highly Cited Researchers 2020 list.

Highly cited researchers banner

The 2020 list of Highly Cited Researchers recognises the world's most influential researchers of the past decade. This is demonstrated by the production of multiple highly-cited papers that rank in the top 1 percent by citations for field and year in Web of Science.

These are the researchers from our Department who have been recognised in this list:

Jesper Andersson

Timothy Behrens

Saad Jbabdi

Mark Jenkinson

Heidi Johansen-Berg

Karla Miller

Peter Rothwell

Stephen Smith

Angela Vincent

Patrick Waters

There are 52 University of Oxford researchers included in the 2020 list – the highest in the UK and the second highest in Europe.

Read more about the Highly Cited Researchers 2020 list.

Similar stories

Attention and memory deficits persist for months after recovery from mild COVID

Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.

New Academic Visitor from Nigeria

Associate Professor of Radiology, Godwin Ogbole has arrived on a six-month visit to the Nuffield Department of Clinical Neurosciences, as part of the Africa Oxford Initiative.

New spinout company: Human-Centric Drug Discovery

Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.

Funding received for research into Motor Neuron Disease

A £210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.

Research finds drug may benefit some patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

Protein test could lead to earlier and better diagnosis of Parkinson’s

Scientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.